Release 5 Preview #3

This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Medicinalproductdefinition-example

Biomedical Research and Regulation Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicinalProductDefinition.

Generated Narrative

id: example

identifier: id: {mpid}

classification: B01AF02

attachedDocument: Generated Summary: id: example; id: urn:oid:1.3.6.1.4.1.21367.2005.3.7.1234; status: current; docStatus: preliminary; Outpatient Note; History and Physical; Arm; Outpatient; General Medicine; period: 23/12/2004 8:00:00 AM --> 23/12/2004 8:01:00 AM; date: 24/12/2005 9:43:41 AM; description: Physical; very restricted

masterFile: Generated Summary: id: example; id: urn:oid:1.3.6.1.4.1.21367.2005.3.7.1234; status: current; docStatus: preliminary; Outpatient Note; History and Physical; Arm; Outpatient; General Medicine; period: 23/12/2004 8:00:00 AM --> 23/12/2004 8:01:00 AM; date: 24/12/2005 9:43:41 AM; description: Physical; very restricted

name

productName: Equilidem 2.5 mg film-coated tablets

namePart

part: Equilidem

type: INV

namePart

part: 2.5 mg

type: STR

namePart

part: film-coated tablets

type: FRM

CountryLanguages

-CountryJurisdictionLanguage
*EUEUEN

ManufacturingBusinessOperations

-TypeEffectiveDateAuthorization
*2013-03-15 --> (ongoing)

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.